ggcmedicines.org.uk - /media/uploads/ps_extra/


[To Parent Directory]

9/22/2020 1:31 PM 126983 appendix_1_summary_table_final_for_web.pdf
9/22/2020 1:31 PM 126467 appendix_2_insulin_summary_table_final_for_web.pdf
9/22/2020 1:31 PM 36864 inhaler_education_wards_for_pilot.doc
9/22/2020 1:31 PM 38795 medicines_update_extra_patient_scenarios_mar_15.pdf
9/22/2020 1:31 PM 38472 medicines_update_extra_qt_prolongation_flowchart_mar_15.pdf
9/22/2020 1:31 PM 86116 medicines_update_extra_qt_prolongation_may_15_incl_hydroxyzine.pdf
9/22/2020 1:31 PM 51136 mu_extra_01_(supp)_-_2014.pdf
9/22/2020 1:31 PM 74543 mu_extra_01_-_2014.pdf
9/22/2020 1:31 PM 335387 mu_extra_03_oab_with_3yr_exp_dec17.pdf
9/22/2020 1:31 PM 43092 mu_extra_04_(scenarios)_-_2015.pdf
9/22/2020 1:31 PM 133216 mu_extra_04_-_2015.pdf
9/22/2020 1:31 PM 275862 mu_extra_04_ppis_with_3yr_exp_dec17.pdf
9/22/2020 1:31 PM 355734 mu_extra_06_nsaids_2017.pdf
9/22/2020 1:31 PM 353233 mu_extra_06_nsaids_with_3_yr_exp_dec_17.pdf
9/22/2020 1:31 PM 838777 mu_extra_07_doac_mar18.pdf
9/22/2020 1:31 PM 179090 mu_extra_08_qt_prolongation_flowchart.pdf
9/22/2020 1:31 PM 232402 mu_extra_08_qt_prolongation_main_bulletin.pdf
9/22/2020 1:31 PM 233937 mu_extra_08_qt_prolongation_patient_scenarios.pdf
9/22/2020 1:31 PM 366141 mu_extra_09_pd.pdf
9/22/2020 1:31 PM 291963 mu_extra_09_pd_scenarios.pdf
9/22/2020 1:31 PM 344854 oab_medicines_update_extra_final_091115.pdf
9/22/2020 1:31 PM 126287 postscript_extra_-_new_oral_anticoagulants_131112.pdf
9/22/2020 1:31 PM 126556 postscript_extra_-_therapies_used_in_the_management_of_diabetes_final_for_web.pdf
9/22/2020 1:31 PM 124401 ps_extra_number_22_jan_2013.pdf
9/22/2020 1:31 PM 62267 pse_02.pdf
9/22/2020 1:31 PM 108168 pse_03.pdf
9/22/2020 1:31 PM 135505 pse_06.pdf
9/22/2020 1:31 PM 118814 pse_14.pdf
9/22/2020 1:31 PM 93375 pse_15.pdf
9/22/2020 1:31 PM 168449 pse_19.pdf
9/22/2020 1:31 PM 179154 pse_20.pdf
9/22/2020 1:31 PM 147506 pse_20s.pdf
9/22/2020 1:31 PM 78162 pse_21.pdf
9/22/2020 1:31 PM 38427 pse_21_(s1).pdf
9/22/2020 1:31 PM 38360 pse_21_(s2).pdf